Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Subjects will continue to be monitored for five years. Medtronic structural heart chief medical officer and vice-president ...

Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...

Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...

The Medtronic Prevail drug coated balloon [Image courtesy of ... presented findings from the Swedish Coronary Angiography and ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...

BL/ - Medtronic, a global leader in healthcare technology, today announced it has received the 2025 World's Most Ethical ...